Feb 15 |
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
|
Feb 14 |
Ironwood Pharmaceuticals Q4 2023 Earnings Preview
|
Feb 14 |
A Preview Of Ironwood Pharmaceuticals's Earnings
|
Feb 5 |
Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable
|
Feb 1 |
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
|
Jan 31 |
Ironwood Pharmaceuticals: Capitalizing On GI Healthcare's Growing Potential
|
Jan 23 |
Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet
|
Jan 9 |
Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation
|
Jan 8 |
Ironwood Pharmaceuticals expects 2024 revenue to be below consensus
|
Jan 8 |
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
|